TotalMarketCap

Jazz Pharmaceuticals

JAZZNasdaq IrelandHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$15.021 B

$231.39 -1.97%

Close of 7 Oct 2026

As of 7 Oct 2026, Jazz Pharmaceuticals (JAZZ) has a market capitalization of $15.0B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$4.27B

#749 by revenue

Earnings

-$356.1M

Loss-making

Shares outstanding

64,914,577

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →
  1. #23InsmedINSM$23.0B
  2. #24ViatrisVTRS$20.1B
  3. #25Jazz PharmaceuticalsJAZZ$15.0B
  4. #26Ascendis Pharma A/SASND$14.9B
  5. #27Summit TherapeuticsSMMT$13.8B

What if Jazz Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.8T

$443,497.22

Per share 1,917× higher

Bitcoin $1.67T

$25,729.93

Per share 111× higher

Nvidia $5.77T

$88,819.56

Per share 384× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Jazz Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.